Trauma Fixation Devices Market Trends

Growth Drivers

• Rising trauma cases: Accidental cases are at a rise globally. In addition, joint and bone issues related diseases are likely to increase among the aged population. As per the report of the National Institute of Health (NIH), fracture expenses for osteoporosis-related fractures cost USD 21 billion annually. Hip fractures are anticipated to accumulate a major market share, with cases doubling by 2030. Demand for trauma cases created an assertive opportunity for the trauma fixation devices to grow.

• Technological advancement: Better research and development scope is exhibiting innovation in the trauma fixation devices. Smart implantation integrated with IoT is a current market trend that ensures efficient procurement of the intervention process. According to the NIH, rapid growth of smart implantation is anticipated in the global market. More than 12 new trauma devices were introduced in the global market through Food and Drug Administration clearance in 2023, which has expanded the adoption rate of trauma fixation devices in the global market.

Manufacturing Strategies to Ensure Surgical Power Tools Market Expansion

Manufacture focused on trauma fixation devices market expansion through varied strategies. Most efficient strategies implemented with a higher level of outcomes included premium product innovation, market localization, and value-based procurement. Companies like Stryker and Zimmer Biomet have accumulated over 7% growth by introducing smart implants and ASC-regulated systems. The cost of imports is controlled at approximately 20% by collaborating with the Indian manufacturers by DePuy Synthes. According to the report published by NIH, more than 65% of the revenue is accumulated by the five leading players in the trauma fixation devices market.   

The following table denotes revenue opportunities for manufacturers:

Key Market Dynamics for Historical Patient Growth

A drastic transformation in the trauma fixation devices market is addressed during the period of 2010 to 2020. Demographic switch and raised injury epidemiology are the primary driving factors of the growth of trauma fixation devices in the addressed period. Approximately 40% and 25% escalation in the patient growth is experienced in the U.S.  and Germany, respectively. The trend of advanced surgery within the health care industry and a higher number of cases in osteoporosis are the market growth drivers in the U.S. and Germany. On the contrary, the markets of China and India experienced more than 30% growth through automation and development within the healthcare infrastructure. Three leading market analyses for patient growth include premiumization in the market of Western countries, cost-driven aspects in the market of Asia, and fulfilling the unaddressed requirements of the aged population.

The following table denotes historical patient growth in the past ten years across different countries:

Challenges

• Government price control and reimbursement policy: Regulatory control on the price fixation of medical devices presents challenging aspects to the trauma fixation devices market growth. For instance, the reduction of the manufacturer's margin up to approximately 20% by the EU Price cap is the key factor behind emerging issues of low revenue accumulation. Approximately 28% of the trauma implant is not accepted by Germany’s IQWiG because of the high cost-bearing threshold of the procurement. Medicare coverage provides minimum insurance that limits the accessibility of trauma fixation devices within the market. As per Medicaid Plain, approximately 40% of the trauma implant coverage is granted, which leads to a delay in surgery for the U.S. patients. Addressing the challenge brings a barrier in accessibility of stakeholders within the concerned market and restrains free growth.